Abstract
In 2020, Chile implemented a DRG payment reform. However, the system imported internationally sources DRG weights instead of using local costs. Thus, there is a need to understand if the current DRG weights accurately represent the local costs of Chilean public providers. This is particularly evident in procedures requiring high-cost medical devices. The Transcatheter Aortic Valve Replacement (TARV) for Aortic Stenosis (AS) has been described as a critical case. We aim to estimate the gap between the current TAVR reimbursement rate and the local provider costs from the public providers' perspective.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have